Literature DB >> 16439168

Endovascular treatment of ruptured and symptomatic abdominal aortic aneurysms.

S Franks1, G Lloyd, G Fishwick, M Bown, R Sayers.   

Abstract

OBJECTIVE: To report the experience of endovascular repair (ER) in patients with ruptured and symptomatic abdominal aortic aneurysms (rAAA and sAAA), comparing results with a cohort of controls who underwent open repair (OR) of sAAA or rAAA.
DESIGN: A historically controlled cohort study. MATERIALS: Retrospective data from 21 patients who underwent ER and prospective data from 23 patients who underwent OR.
METHODS: Results were compared using the Mann-Whitney U-test.
RESULTS: Eleven ER patients had sAAAs and 10 had rAAAs. Nine OR patients had rAAAs and 13 had sAAAs. Thirty-day mortality was 11% in patients with rAAA in the ER group, and 54% in the OR group (p=0.03). There were no post-operative deaths in the patients who had an sAAA in the ER group, and one death in the patients who had sAAA in the OR group. Results as expressed as mean ER value versus mean OR value and p-value. ER was associated with significant reductions in the length of operation (2.6 versus 3.1h, p=0.03), blood transfusion requirements (0.86 versus 10.7 units p<0.01), time in critical care (1.5 versus 6.1 days, p=0.02), and total hospital stay (8.5 versus 17.5 days, p=0.01) compared with OR. There was no difference in time from admission to arrival in theatre between the two groups (3.4 versus 5.0h, p=0.35).
CONCLUSIONS: In patients with rAAA and sAAA that are suitable for stenting, ER has reduced mortality compared with open repair. Assessment for ER does not cause a pre-operative delay, operating time is reduced, blood transfusion requirements are reduced and there is a faster recovery.

Entities:  

Mesh:

Year:  2006        PMID: 16439168     DOI: 10.1016/j.ejvs.2005.08.037

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  7 in total

1.  Outcomes of symptomatic abdominal aortic aneurysm repair.

Authors:  Randall R De Martino; Brian W Nolan; Philip P Goodney; Catherine K Chang; Andres Schanzer; Robert Cambria; Daniel J Bertges; Jack L Cronenwett
Journal:  J Vasc Surg       Date:  2010-05-14       Impact factor: 4.268

2.  Endovascular repair of thoracic and abdominal aortic ruptures: a single-center experience.

Authors:  Filiz İslim; Aysun Erbahçeci Salık; Koray Güven; Vedat Bakuy; Zafer Çukurova
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

3.  Outcomes for symptomatic abdominal aortic aneurysms in the American College of Surgeons National Surgical Quality Improvement Program.

Authors:  Peter A Soden; Sara L Zettervall; Klaas H J Ultee; Jeremy D Darling; Dominique B Buck; Chantel N Hile; Allen D Hamdan; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2016-04-14       Impact factor: 4.268

Review 4.  Virtual reality simulation for the optimization of endovascular procedures: current perspectives.

Authors:  Nung Rudarakanchana; Isabelle Van Herzeele; Liesbeth Desender; Nicholas J W Cheshire
Journal:  Vasc Health Risk Manag       Date:  2015-03-10

5.  Long-term outcome of ruptured abdominal aortic aneurysm: impact of treatment and age.

Authors:  Jelle W Raats; Hans C Flu; Gwan H Ho; Eelco J Veen; Louwerens D Vos; Ewout W Steyerberg; Lijckle van der Laan
Journal:  Clin Interv Aging       Date:  2014-10-13       Impact factor: 4.458

Review 6.  Open versus Endovascular Repair of Abdominal Aortic Aneurysm in the Elective and Emergent Setting in a Pooled Population of 37,781 Patients: A Systematic Review and Meta-Analysis.

Authors:  Dustin M Thomas; Edward A Hulten; Shane T Ellis; David M F Anderson; Nathan Anderson; Fiora McRae; Jamil A Malik; Todd C Villines; Ahmad M Slim
Journal:  ISRN Cardiol       Date:  2014-04-02

Review 7.  Endovascular vs. Open Repair for Ruptured Abdominal Aortic Aneurysm.

Authors:  Nikolaos Patelis; Demetrios Moris; Georgios Karaolanis; Sotiris Georgopoulos
Journal:  Med Sci Monit Basic Res       Date:  2016-04-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.